Your session is about to expire
← Back to Search
Behavioral Intervention
Meditation Program for Cancer Patients and Caregivers
N/A
Recruiting
Led By Kathrin Milbury, MD,PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have an ECOG performance status of ≤2
Be diagnosed with a metastatic (stage IV) breast, thoracic, gastrointestinal, gynecological, or genitourinary cancer
Must not have
Children under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to understand how two different support programs can impact the mental health and quality of life of patients and their family caregivers."
Who is the study for?
This trial is for adults with stage IV breast, thoracic, gastrointestinal, gynecological, or genitourinary cancer who've had no disease progression for at least 3 months. They must have a caregiver willing to join the study and both should be able to understand English or Spanish. Participants need an ECOG performance status of ≤2 and a distress score ≥4.
What is being tested?
The study examines the impact of two different supportive care programs on psychological wellbeing and quality of life in patients with advanced cancer and their caregivers. It involves a meditation program designed to help manage psycho-spiritual aspects related to cancer.
What are the potential side effects?
Since this trial focuses on meditation as an intervention rather than medication, there are no typical drug side effects; however, participants may experience emotional discomfort when discussing personal issues during sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am able to care for myself and perform daily activities.
Select...
I have been diagnosed with stage IV cancer in breast, lung, stomach, reproductive organs, or urinary system.
Select...
I and my caregiver are both over 18 years old.
Select...
My cancer has not worsened in the last 3 months according to CT scans.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion; an average of 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Depressive Symptoms
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
All participants will receive cancer treatment per usual care (UC).
Group II: Behavioral Intervention (FFM Program)Experimental Treatment1 Intervention
Participants will take part in a discussion program. Participants will be asked to complete 4 discussion sessions with a trained counselor over a course of a 4 week period. Participants should attend each session together as a family.
Group III: Attention ControlExperimental Treatment1 Intervention
Participants will take part in a meditation program. As part of this program, participants will complete up to 4 meditation sessions with a trained counselor. Participants should attend each session together as a family. All sessions will be online by videoconference using Zoom.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,059 Previous Clinical Trials
1,800,268 Total Patients Enrolled
Kathrin Milbury, MD,PHDPrincipal InvestigatorMD Anderson
Share this study with friends
Copy Link
Messenger